KIM DUNG T NGUYEN

Allopathic & Osteopathic Physicians|Internal Medicine ALEXANDRIA, VA NPI 1013953397

General Payments — all program years on this page

$815.17

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $325.25 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $325.2515

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $86.313
Novo Nordisk AS $61.713
Acerta Pharma LLC $51.883
Agios Pharmaceuticals, Inc. $39.942
Lilly USA, LLC $35.202
Exact Sciences Corporation $34.901
Astellas Pharma US Inc $15.311

By program year

Program yearAmountRecords
2019 $242.013
2021 $46.263
2022 $15.131
2023 $186.528
2024 $325.2515

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096567960 Novo Nordisk Inc $20.50 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096718028 Novo Nordisk Inc $15.72 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097629407 Novo Nordisk Inc $25.49 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104312928 AstraZeneca Pharmaceuticals LP $19.97 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104381307 AstraZeneca Pharmaceuticals LP $14.96 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104679811 AstraZeneca Pharmaceuticals LP $16.95 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114808840 Exact Sciences Corporation $34.90 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117339809 Amgen Inc. $38.42 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117339811 Amgen Inc. $21.27 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117339813 Amgen Inc. $26.62 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135122931 Lilly USA, LLC $17.12 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135132431 Lilly USA, LLC $18.08 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139298288 Astellas Pharma US Inc $15.31 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149640549 Agios Pharmaceuticals, Inc. $24.63 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149641316 Agios Pharmaceuticals, Inc. $15.31 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.